您现在的位置是:知識 >>正文
【】
知識6425人已围观
简介The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a ...
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
Featured Video For You
This biosensor allows doctors to monitor a patient's vitals from anywhere
TopicsHealth
Tags:
转载:欢迎各位朋友分享到网络,但转载请说明文章出处“夫榮妻貴網”。http://new.maomao321.com/news/76d54799376.html
相关文章
Early Apple
知識One of the first Apple computers ever made is currently up for auction.A rare "Celebration" Apple-1 ...
【知識】
阅读更多Twitch's new content tags are long overdue but they'll need back
知識With a bit more than a week to go before Pride Month kicks off on June 1, Twitch is launching a new ...
【知識】
阅读更多Clubhouse data for 1.3 million users leaks online
知識Large-scale data leaks have become almost a rite of passage for new social networks. If Clubhouse wa ...
【知識】
阅读更多
热门文章
最新文章
Snapchat is about to explode in popularity, report says
Samsung's new Galaxy A series phones offer options for all budgets
Facebook says it'll ban anti
Bowers & Wilkins' Pi7 earbuds: Great sound and noise cancellation
Here's what 'Game of Thrones' actors get up to between takes
Apple will replace some MacBook Pro batteries for free